en
svPress releases
Regulatory press release 2020-08-21
Warrant holders exercise all warrants within the framework of incentive program
Regulatory press release 2020-08-18
Xspray strengthens the value of the product portfolio with patent protection for tablet of dasatinib propylene glycol solvate
Regulatory press release 2020-08-12
Xspray announces preliminary results from the first study for its lead product candidate HyNap-Dasa
Press release 2020-08-03
Xspray enters manufacturing collaboration in Malta
Regulatory press release 2020-07-31
Xspray Pharma publishes Interim Report Q2, January – June 2020
Press release 2020-07-03
First study group has been dosed in Xspray Pharma’s ongoing pivotal registration studies with HyNap-Dasa
Press release 2020-06-25
Xspray – Virtual Capital Markets Day today at 14.00 CET
Press release 2020-06-18
Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET
Regulatory press release 2020-05-29
Xspray Pharma initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States
Regulatory press release 2020-05-14